Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - the impact of fibrosarcomatous transformation by Rutkowski, Piotr, Klimczak, Anna, Ługowska, Iwona, Jagielska, Beata, Wągrodzki, Michal, Dębiec-Rychter, Maria, Pieńkowska-Grela, Barbara, Świtaj, Tomasz

Get full text

Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas by Koseła-Paterczyk, H, Szacht, M, Morysiński, T, Ługowska, I, Dziewirski, W, Falkowski, S, Zdzienicki, M, Pieńkowski, A, Szamotulska, K, Świtaj, T, Rutkowski, P

Get full text

The impact of unplanned surgery and adherence to practice guidelines on outcomes of patients with osteosarcoma by Lugowska, I, Pienkowski, A, Goryn, T, Szumera-Cieckiewicz, A, Kosela-Paterczyk, H, Teterycz, P, Katarzyna, K, Falkowski, S, Rutkowski, P

Get full text

Merkel-cell carcinoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up by Lugowska, I., Becker, J.C., Ascierto, P.A., Veness, M., Blom, A., Lebbe, C., Migliano, E., Hamming-Vrieze, O., Goebeler, M., Kneitz, H., Nathan, P., Rutkowski, P., Slowinska, M., Schadendorf, D., Piulats, J.M., Petrelli, F., van Akkooi, A.C.J., Berruti, A.

Get full text

A phase Ib/II dose expansion study of subcutaneous sasanlimab in patients with locally advanced or metastatic non-small-cell lung cancer and urothelial carcinoma by Cho, B.C., Penkov, K., Bondarenko, I., Kurochkin, A., Pikiel, J., Ahn, H.K., Korożan, M.E., Osipov, M., Odintsova, S., Braiteh, F., Ribas, A., Grilley-Olson, J.E., Lugowska, I., Bonato, V., Damore, M.A., Yang, W., Jacobs, I.A., Bowers, M., Li, M., Johnson, M.L.

Get full text

107. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate by Rutkowski, P, Klimczak, A, Switaj, T, Jagielska, B, Lugowska, I, Wagrodzki, M, Debiec-Rychter, M, Woroniecka, R, Pienkowska-Grela, B

Get full text

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer by Galffy, G., Lugowska, I., Poddubskaya, E.V., Cho, B.C., Ahn, M.-J., Han, J.-Y., Su, W.-C., Hauke, R.J., Dyar, S.H., Lee, D.H., Serwatowski, P., Estelles, D.L., Holden, V.R., Kim, Y.J., Vladimirov, V., Horvath, Z., Ghose, A., Goldman, A., di Pietro, A., Wang, J., Murphy, D.A., Alhadab, A., Laskov, M.

Get full text

3348 Cell-free DNA V600E measurements during vemurafenib therapy of metastatic melanoma patients by Kozak, K, Lugowska, I, Kowalik, A, Gos, A, Jurkowska, M, Stępniak, J, Switaj, T, Paterczyk, H. Kosela, Klimczak, A, Falkowski, S, Jagielska, B, Siedlecki, J, Chlopek, M, Kalisz, J, Rutkowski, P

Get full text

3425 The prognostic value of changes over time of HER-2/ECD concentration in osteosarcoma patients by Lugowska, I, Szamotulska, K, Klepacka, T, Ambroszkiewicz, J, Grygalewicz, B, Michalak, E, Gajewska, J, Lenarcik, M, Koch, I, Pieńkowska-Grela, B, Mierzejewska, E, Rutkowski, P

Get full text

3313 The next generation sequencing (NGS) analysis of selected genes and pathways in clinical stage III cutaneous melanoma by Lugowska, I, Mierzejewska, E, Kowalik, A, Gos, A, Zięba, S, Siedlecki, J, Kosea-Paterczyk, H, Szumera-Ciéckiewicz, A, Jurkowska, M, Rutkowski, P

Get full text

PP 55 Serum levels of the extracellular domain of HER-2 receptor in osteosarcoma patients by Lugowska, I, Wożniak, W, Szamotulska, K, Ambroszkiewicz, J, Gajewska, J, Rutkowski, P

Get full text

PCN45 Epidemiology, Treatment Patterns and Costs in Patients With Stage III/IV Melanoma by Lugowska, I, Szkutecka-Debek, M, Sozanska-Solak, A, Ziobro, M, Wysocki, P, Barszcz, E, Jakubczyk, M, Niewada, M

Get full text

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study by Pant, Shubham, Schuler, Martin, Iyer, Gopa, Witt, Olaf, Doi, Toshihiko, Qin, Shukui, Tabernero, Josep, Lugowska, Iwona, Carranza, Omar, Arnold, Dirk, Gutierrez, Martin, Winter, Helen, Stuyckens, Kim, Crow, Lauren, Najmi, Saltanat, Thomas, Shibu, Santiago-Walker, Ademi, Triantos, Spyros, Sweiti, Hussein, Loriot, Yohann, Carranza, Omar, Coward, Jim, Joshua, Anthony, Karapetis, Christos, Hart, Christopher, Zhang, Alison, Prenen, Hans, Goeminne, Jean-Charles, Machiels, Jean-Pascal, Rottey, Sylvie, Corassa, Marcelo, Molin, Graziela Zibetti Dal, Tiscoski, Katsuki, Mak, Milena, Fu, Wei, Yao, Herui, Jiang, Haiping, Qin, Shukui, Chen, Baoshi, Yang, Yu, Loriot, Yohann, Le Tourneau, Christophe, Penel, Nicolas, Durando, Xavier, Emambux, Sheik, Folprecht, Gunnar, Arnold, Dirk, Schuler, Martin, Ahrens, Marit, Golf, Alexander, Haag, Georg Martin, Desuki, Alexander, Cazzaniga, Marina, Ciardiello, Fortunato, Koyama, Takafumi, Aogi, Kenjiro, Kuboki, Yasutoshi, Lee, Jungyun, Kim, Sung-Bae, Chang, Jong Hee, Kim, Yong-Man, Nam, Do-Hyun, Park, Jae-Sung, Lugowska, Iwona, Paz-Ares, Luis, Moreno, Victor, Calvo, Mariona, Falcon, Alejandro, Gonzalez, Antonio, Tabernero, Josep, Martinez Bueno, Alejandro, García-Corbacho, Javier, Chen, Jen-Shi, Hou, Ming-Feng, Chao, Yee, Rau, Kun-Ming, Chiu, Tai-Jan, Feng, Yin-Hsun, Hsu, Chih-Hung, Lai, Kuan-Ming, Yeh, Su-peng, Minchom, Anna, Welsh, Liam, Plummer, Ruth, Gutierrez, Martin, Arrowsmith, Edward, Pant, Shubham, Spigel, David Robert, Zandberg, Dan Paul, Doroshow, Deborah, Moezi, Mehdi, Paulson, Scott, Reardon, David, Ward, Patrick, Chaves, Jorge, Hussein, Atif, Manda, Sudhir, Richey, Stephen L, Tamura, David, Wilks, Sharon

Get full text

Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors by Dziadziuszko, R., Garralda Cabanas, E., Rojas, K., Chelstowska, M., Blaszkowska, M., Dudziak, R., Rzymski, T., Angelosanto, N., Littlewood, P., Nogai, H., Boni, V., Lugowska, I.

Get full text

157P PCM4EU academy: An educational program for precision oncology by Verlingue, L., Antouly, M., Witczak, M., Blay, J-Y., Lugowska, I.

Get full text

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe by Taskén, Kjetil, F Haj Mohammad, Soemeya, Fagereng, Gro Live, Sørum Falk, Ragnhild, Helland, Åslaug, Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Steen Carlsson, Katarina, Ryll, Bettina, Jalkanen, Katriina, Edsjö, Anders, Russnes, Hege G, Lassen, Ulrik, Hallersjö Hult, Ebba, Lugowska, Iwona, Blay, Jean-Yves, Verlingue, Loic, Abel, Edvard, Lowery, Maeve A, Krebs, Matthew G, Staal Rohrberg, Kristoffer, Ojamaa, Kristiina, Oliveira, Julio, Verheul, Henk M W, Voest, Emile E, Gelderblom, Hans

Get full text

High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond by Edsjö, Anders, Russnes, Hege G., Lehtiö, Janne, Tamborero, David, Hovig, Eivind, Stenzinger, Albrecht, Rosenquist, Richard, Janowska, Agnieszka, Rioja, Alba López, Stenzinger, Albrecht, Razzak, Ali, Edsjö, Anders, Lepland, Anni, Marra, Antonio, Planken, Anu, Helland, Åslaug, Patocs, Attila, Mainoli, Beatrice, Ryll, Bettina, Brasiuniene, Birute, Kazdal, Daniel, Tamborero, David, Cerina, Dora, Hult, Ebba Hallersjö, Baltruškevičienė, Edita, Vrdoljak, Eduard, Hovig, Eivind, Chavarria, Elena, Garralda, Elena, Aas, Eline, Bjørgo, Elisa, Voest, Emile, Curigliano, Giuseppe, Fagereng, Gro Live, Gelderblom, Hans, Russnes, Hege G., Verheul, Henk, Timmer, Hans, Brana, Irene, Lugowska, Iwona, Lehtiö, Janne, Blay, Jean‐Yves, Oliveira, Julio, Rekker, Kadri, Toome, Kadri, Jalkanen, Katriina, Taskén, Kjetil, Smeland, Knut, Ojamaa, Kristiina, Rohrberg, Kristoffer Staal, Verlingue, Loic, Antouly, Manon, Mustonen, Mika, Zagami, Paola, Nagy, Péter, Nygren, Peter, Asplund, Peter, Sabaliauskaite, Rasa, Rosenquist, Richard, Henrique, Rui, Waalwijk van Doorn‐Khosrovani, Sahar Barjesteh, Brabrand, Sigmund, Ekman, Simon, Mohammad, Soemeya Haj, Jarmalaite, Sonata, Juslin, Tanja, Kahre, Tiina, Kringelbach, Tina, Guren, Tormod, Lassen, Ulrik, Grolmusz, Vince Kornél, Alberu, Xenia Villabour

Get full text

Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring by Horgan, Denis, Čufer, Tanja, Gatto, Francesco, Lugowska, Iwona, Verbanac, Donatella, Carvalho, Ângela, Lal, Jonathan A, Kozaric, Marta, Toomey, Sinead, Ivanov, Hristo Y, Longshore, John, Malapelle, Umberto, Hasenleithner, Samantha, Hofman, Paul, Alix-Panabières, Catherine

Get full text

4117 The extracellular domain of HER-2 as a potential marker for treatment monitoring in osteosarcoma by Lugowska, I, Wozniak, W, Ambroszkiewicz, J, Gajewska, J, Szamotulska, K

Get full text

61MO Phase Ia/Ib study of the MDM2-p53 antagonist brigimadlin (BI 907828) in advanced solid tumours: Overall safety, and efficacy in patients (pts) with well-differentiated liposar... by Reichardt, P., Schöffski, P., Lorusso, P., Yamamoto, N., Garcia, V. Moreno, Lugowska, I., Lauer, U., Somaiah, N., Hu, C., Landsteiner, H.T., Jayadeva, G., Gounder, M.

Get full text